Indeed, we found breast cancer cells, which revealed susceptible to ASCs (KBr1, KBr2 and MDA-MB-231), expressed higher levels of c-Met in comparison with breast cancer cells whose behaviour did not change in presence of ASCs (KBr3, KBr4, MCF7) (Figure 2 and 8). The gene discussed is MET; the disease is breast carcinoma.